Biotech companies report on drugs to treat head and neck, lung cancers

06/7/2004 | Reuters · Wall Street Journal, The

Genentech and ImClone reported success in developing a pair of drugs that treat head and neck cancer and lung cancer, respectively. Genentech said combining its Tarceva and Avastin can extend the survival rate of patients with lung cancer and ImClone said Erbitux, FDA-approved for treating colon cancer, can work with radiation to increase the median survival rate of patients with head and neck cancer.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT